News for Gilead Science (GILD)
| | | News for Gilead Sciences Inc. (GILD) | | | | |
| | | 9:31 AM | Seven Summits Research Releases Comments on KO, GILD, NUE, JNJ and UTX - PR Newswire | |
| | | 4:31 PM | Gilead Sciences to Release Third Quarter 2008 Financial Results on Thursday, October 16, 2008 - Business Wire | |
| | | 9:31 AM | Seven Summits Research Releases Alerts on RIG, MCD, APA, GILD, and GD - PR Newswire | |
| | | 6:54 PM | Gilead Receives Complete Response Letter from U.S. Food and Drug Administration for Aztreonam Lysine for Inhalation, an Investigational Treatment for Cystic Fibrosis - Business Wire | |
| | | 10:20 AM | Beacon Equity Issues Trade Alerts on Recent Analyst Upgrades: PBG, LCC, GILD, ORA, OPTV, SYT - PR Newswire | |
| | | 4:52 PM | Seigo Izumo, MD Joins Gilead as Senior Vice President, Cardiovascular Therapeutics - Business Wire | |
| | | 5:30 PM | Gilead Sciences to Present at Two Upcoming Investor Conferences - Business Wire | |
| | | 9:31 AM | Seven Summits Research Releases Alerts on POT, JPM, GILD, LMT, and ICE - PR Newswire | |
| | | 10:51 AM | BeaconEquity.com Issues Technical Trade Alerts on BioPharmaceutical Stocks: CEGE, AMLN, DNA, GENZ, AMGN, GILD - PR Newswire | |
| | | 4:16 PM | Gilead Sciences to Present at the Thomas Weisel Partners Healthcare Conference on Wednesday, September 3 - Business Wire | |
| | | 10:20 AM | BeaconEquity.com Issues Trade Alerts on Biotechnology Stocks: ELN, PFE, AMGN, DNA, BIIB, GILD - PR Newswire | |
| | | 6:08 PM | U.S. Food and Drug Administration Approves Viread(R) for Chronic Hepatitis B in Adults - Business Wire | | 9:31 AM | Seven Summits Research Releases Alerts on GOOG, MS, GILD, MMM, and AGU - PR Newswire | |
| | | 8:34 AM | Gilead Sciences and Merck & Co., Inc. Enter Into an Agreement to Register and Distribute HIV Medication Atripla(R) (Efavirenz 600 mg/ Emtricitabine 200 mg/ Tenofovir Disoproxil Fumarate 300 mg) in Twelve Countries - Business Wire | |
| | | 11:05 AM | Richard J. Whitley, MD Joins Gilead Sciences' Board of Directors - Business Wire | |
| | | 4:19 PM | Gilead Initiates Phase III Clinical Trial of Elvitegravir, an Investigational Integrase Inhibitor for HIV - Business Wire | |
| | | 4:18 PM | Gilead Sciences Announces Second Quarter 2008 Financial Results - Business Wire | |
| | | 4:19 PM | Gilead Sciences to Release Second Quarter 2008 Financial Results on Thursday, July 17, 2008 - Business Wire | |
| | | 8:59 AM | Gilead's cystic fibrosis drug meets safety goal and Polydex Reports First Quarter Financial Results - U.S. Equity News | |
| | | 8:45 AM | Gilead Announces Interim 12-Month Phase III Study Results for Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis - Business Wire | |
| | | 4:20 PM | Gilead Sciences to Present at the 29th Annual Goldman Sachs Global Healthcare Conference on Wednesday, June 11 - Business Wire | | 12:08 PM | BellwetherReport.com Analyst Report on ONNN, NVTL, GILD and GT - Marketwire | |
| | | 1:39 PM | U.S. Patent Office Confirms Second of Four Viread(R) Patents - Business Wire | | 9:20 AM | BeaconEquity.com Issues TraderNotes on Biotechnology Stocks: TPIM, RXII, VION, CUR, AMGN, GILD, BIIB, GENR - PR Newswire | |
| | | 4:15 PM | Gilead and Navitas Announce Agreement for Cicletanine for the Treatment of Pulmonary Arterial Hypertension - Business Wire | | | | |
Copyright © QuoteMedia. Data delayed at least 15 min. unless otherwise indicated. RT Realtime, EOD End Of Day, PD Previous Day. Market Data powered by QuoteMedia. Terms of Use. | |
| |
Research Report
Hotstocked.com has a complete research report available for GILD stock.
Download GILD report.
Research Report
Get the full report for FREE
| Date: | Sep 2, 2008 |
|---|
| Price: | Free |
|---|
| Pages: | 4 |
|---|
| Document Type: | Adobe Acrobat Reader |
|---|
| | Download GILD report |
|---|
| | |
|---|
| Example preview: |
|
|
